Načítá se...
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections
INTRODUCTION: Oritavancin is a novel lipoglycopeptide approved for acute bacterial skin and skin structure infections. The pharmacokinetic profile and convenient one-time dosing make oritavancin an enticing option for other serious Gram-positive infections requiring prolonged treatment courses. Unfo...
Uloženo v:
| Vydáno v: | Infect Dis Ther |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5446369/ https://ncbi.nlm.nih.gov/pubmed/28386776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-017-0156-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|